Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

ILLUMINA, INC.

(ILMN)
  Report
Delayed Quote. Delayed Nasdaq - 10/23 04:00:00 pm
323.55 USD   -0.73%
10/07ILLUMINA, INC. : Report
CO
10/05ILLUMINA, INC. : Report
CO
10/01ILLUMINA, INC. : Report
CO
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Illumina : Confirms Deal For Grail

share with twitter share with LinkedIn share with facebook
09/21/2020 | 07:37am EDT

By Micah Maidenberg

 

Illumina Inc. said Monday it has agreed to purchase Grail Inc. in a cash-and-stock deal that would give Illumina control of the developer of a blood test that aims to detect cancer in its early stages.

Grail was founded by Illumina in 2016 and spun out into a separate company, Illumina said. The company had raised about $2 billion to support its technology platform and the Galleri tool. Galleri, the cancer testing platform that analyzes patients' blood, is expected to launch next year commercially.

Illumina said it will pay $3.5 billion in cash and provide $4.5 billion in its common stock to Grail shareholders to complete the transaction. Illumina currently owns 12% of Grail shares on a fully diluted basis.

The so-called "collar" on the stock portion of the planned acquisition will ensure the Grail stockholders receive Illumina shares that are equal to about $4 billion in value, the companies said.

The Wall Street Journal earlier reported that Illumina's acquisition for Grail was imminent.

"As we accelerate our path to clinical leadership and the path to multi-cancer early detection, we will continue to drive significant value creation for our stockholders," Illumina Chief Executive Francis deSouza said in a statement.

 

Write to Micah Maidenberg at micah.maidenberg@wsj.com

 


share with twitter share with LinkedIn share with facebook
All news about ILLUMINA, INC.
10/07ILLUMINA, INC. : Report
CO
10/05ILLUMINA, INC. : Report
CO
10/01ILLUMINA, INC. : Report
CO
09/28ILLUMINA : to Announce Third Quarter 2020 Financial Results on Thursday, October..
BU
09/25JOHNSON & JOHNSON, NIKE, ILLUMINA : Stocks That Defined the Week
DJ
09/23ILLUMINA : to Webcast Upcoming Investor Conference Presentation
BU
09/21Nikola, Illumina fall; Cubic, Rent-A-Center rise
AQ
09/21Nikola, Illumina fall; Cubic, Rent-A-Center rise
AQ
09/21Illumina to buy Jeff Bezos-backed cancer testing firm Grail in £6.23 billion ..
RE
09/21JEFF BEZOS : Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 b..
RE
More news
Financials (USD)
Sales 2020 3 095 M - -
Net income 2020 550 M - -
Net cash 2020 2 068 M - -
P/E ratio 2020 87,9x
Yield 2020 -
Capitalization 47 355 M 47 355 M -
EV / Sales 2020 14,6x
EV / Sales 2021 11,8x
Nbr of Employees 7 700
Free-Float 75,1%
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Average target price 297,25 $
Last Close Price 323,55 $
Spread / Highest target 17,4%
Spread / Average Target -8,13%
Spread / Lowest Target -32,0%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Robert P. Ragusa Senior Vice President-Global Quality & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Phillip G. Febbo Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.-2.47%47 355
THERMO FISHER SCIENTIFIC47.80%189 950
DANAHER CORPORATION51.59%165 276
INTUITIVE SURGICAL, INC.24.42%86 460
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.95.16%64 541
BOSTON SCIENTIFIC CORPORATION-17.80%53 178